EEC syndrome type 3 with a heterozygous germline mutation in the P63 gene and B cell lymphoma

American Journal of Medical Genetics

Volumn 120 A, Issue 3, 2003, Pages 370-373

  Akahoshi, Keiko ^a,e   Sakazume, Satoru ^b   Kosaki, Kenjiro ^c   Ohashi, Hirofumi ^d   Fukushima, Yoshimitsu ^b  

^a Shimada Ryoiku Center   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^e Tokyo Pediatric Ryoiku Hospital   (Japan)

Author keywords

Apoptosis; B cell lymphoma; EEC syndrome; p63

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53; PROTEIN P63;

ADOLESCENT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE COURSE; ECTRODACTYLY ECTODERMAL DYSPLASIA CLEFTING SYNDROME TYPE 3; FEMALE; GENE MUTATION; GENE SEQUENCE; GERM LINE; HETEROZYGOSITY; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADOLESCENT; DNA-BINDING PROTEINS; ECTODERMAL DYSPLASIA; FEMALE; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; JAPAN; LYMPH NODES; LYMPHOMA, B-CELL; PHOSPHOPROTEINS; SYNDROME; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0041823217     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Bincky A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD, Santibanez-Koref MF. 1994. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298-1304.
2. Brunner HG, Hamel BC, Van Bokhoven H. 2002. Thep63 gene in EEC and other syndromes. J Med Genet 39:377-381.
3. Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H. 1999. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99:143-153.
4. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. 2002. P63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501.
5. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T. 2002. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564.
6. Fukushima Y, Ohashi H, Hasegawa T. 1993. The breakpoints of the EEC syndrome (ectrodactyly, ectodermal dysplasia and cleft lip/palate) confirmed to 7q11.21 and 9p12 by fluorescence in situ hybridization. Clin Genet 44:50.
7. Gershoni-Baruch R, Goldscher D, Hochberg Z. 1997. Ectrodactyly-ectodermal dysplasia-clefting syndrome and hypothalamo-pituitary insufficiency. Am J Med Genet 68:168-172.
8. Ianakiev P, Kilpatrick MW, Toudjarska I, Basel D, Beighton P, Tsipouras P. 2000. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 67:59-66.
9. Kosaki R, Ohashi H, Yoshihashi H, Suzuki T, Kosaki K. 2001. A de novo mutation (R279C) in thep63 gene in a patient with EEC syndrome. Clin Genet 60:314-315.
10. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. 2000. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J Cell Sci 113:1661-1670.
11. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bladley A. 1999. p63 is a p53 homologue required for limb and epidemal morphogenesis. Nature 398:708-713.
12. O'Quinn JR, Hennekam RCM, Jorde LB, Bamshad M. 1997. Syndromic ectrodactyly with severe limb, ectodermal, urogenital, and palatal defects maps to chromosome 19. Am J Hum Genet 61(suppl.): A289.
13. Ogutcen-Toller M, Gulen O, Okten G, Elbistan M. 2000. Non-Hodgkin's lymphoma in a patient with ectrodactyly ectodermal dysplasia-clefting syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:124-125.
14. Penchaszadeh VB, de Negrotti TC, 1976. Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome: Dominant inheritance and variable expression. J Med Genet 13:281-284.
15. Qumsiyeh MB. 1992. EEC syndrome (ectrodactyly, ectodermal dysplasia and cleft lip/palate) is on 7p11.2-q21.3. Clin Genet 42:101.
16. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. 1990. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749.
17. van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beermer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG. 2001. p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 69:481-492.
18. Wessagowit V, Mellerio JE, Pembroke AC, McGrath JA. 2000. Heterozygous germline missense mutation in the p63 gene underlying EEC syndrome, Clin Exp Dermatol 25:441-443.
19. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeron F. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316.